chr8-89981483-T-TTA
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_002485.5(NBN):c.210_211dupTA(p.Asn71IlefsTer22) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_002485.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- Nijmegen breakage syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- idiopathic aplastic anemiaInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002485.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NBN | NM_002485.5 | MANE Select | c.210_211dupTA | p.Asn71IlefsTer22 | frameshift | Exon 3 of 16 | NP_002476.2 | ||
| NBN | NM_001024688.3 | c.-37_-36dupTA | 5_prime_UTR | Exon 4 of 17 | NP_001019859.1 | ||||
| NBN | NM_001440379.1 | c.-37_-36dupTA | 5_prime_UTR | Exon 3 of 16 | NP_001427308.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NBN | ENST00000265433.8 | TSL:1 MANE Select | c.210_211dupTA | p.Asn71IlefsTer22 | frameshift | Exon 3 of 16 | ENSP00000265433.4 | ||
| NBN | ENST00000697309.1 | c.210_211dupTA | p.Asn71IlefsTer22 | frameshift | Exon 3 of 15 | ENSP00000513244.1 | |||
| NBN | ENST00000697293.1 | c.210_211dupTA | p.Asn71IlefsTer22 | frameshift | Exon 3 of 17 | ENSP00000513230.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Microcephaly, normal intelligence and immunodeficiency Pathogenic:1
This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Asn71Ilefs*22) in the NBN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NBN are known to be pathogenic (PMID: 9590180, 16415040). This variant has not been reported in the literature in individuals with NBN-related conditions. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at